Christoph Röllig, MD, MSC^1*, Björn Steffen, MD^2*, Christoph Schliemann, MD^3*, Jan-Henrik Mikesch, PD, MD^3*, Nael Alakel, MD^4*, Regina Herbst, MD^5*, Mathias Haenel, MD^6*, Richard Noppeney, MD^7*, Maher Hanoun, MD, PhD^8*, Martin Kaufmann, MD⁹, Zdenek Racil, MD^10*, Kerstin Schäfer-Eckart^11*, Tim Sauer, MD^12*, Andreas Neubauer, MD¹³, Claudia D. Baldus, MD^14*, Jolana Mertova^15*, Edgar Jost^16*, Dirk Niemann, MD^17*, Jan Novak^18*, Stefan W. Krause, MD^19*, Sebastian Scholl, MD^20*, Andreas Hochhaus²¹, Gerhard Held, Professor Dr^22*, Tomáš Szotkowski, MD, PhD^23*, Christoph Schmid, MD^24*, Andreas Rank, MD^25*, Lars Fransecky, MD^26*, Michael Kramer, MSc^27*, Frank Fiebig^28*, Annett Haake^28*, Friedrich Stoelzel, MD²⁹, Johannes Schetelig, MD, MSc³⁰, Jan Moritz Middeke, MD^29*, Uwe Platzbecker, MD^31*, Christian Thiede, MD²⁷, Carsten Müller-Tidow, MD^12*, Wolfgang E. Berdel, MD³², Hubert Serve, MD², Gerhard Ehninger, MD³³, Jiří Mayer, MD³⁴ and Martin Bornhaeuser, MD³⁵

¹Universitätsklinikum Carl Gustav Carus, Dresden, Germany
²Department of Medicine II, Hematology/Oncology, Goethe University Hospital, Frankfurt, Germany
³Department of Hematology, Oncolog and Pneumology, University of Münster, Münster, Germany
⁴University Hospital TU Dresden, Germany, Dresden, Germany
⁵Klinikum Chemnitz, Chemnitz, DEU
⁶Medizinische Klinik III, Klinikum Chemnitz, Chemnitz, Germany
⁷Department of Hematology and Stem Cell Transplantation, University Hospital of Essen, Essen, Germany
⁸Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany
⁹Medical Centre, Robert-Bosch-Hospital,, Stuttgart, Germany
¹⁰Masaryk University Hospital Brno, Brno, CZE
¹¹Department of Internal Medicine V, Nuremberg Hospital North, Paracelsus Medical University, Nuremberg, Germany
¹²Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
¹³Klinik für Innere Medizin, Schwerpunkt Hämatologie, Onkologie und Immunologie, Philipps University, Marburg, Germany
¹⁴Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Kiel, Germany
¹⁵UHKT, Prague, Czech Republic
¹⁶University Hospital Aachen, Germany, Aachen, Germany
¹⁷Department of Hematology/Oncology and Palliative Medicine, Ev. Stift St. Martin, Koblenz, Germany
¹⁸University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles U, Prague, CZE
¹⁹University Hospital Erlangen, Germany, Erlangen, Germany
²⁰University Hospital Jena, Jena, Germany
²¹Department of Internal Medicine 2, Hematology and Oncology, Jena University Hospital, Jena, Germany
²²Department of Internal Medicine I, Westpfalz-Klinikum, Kaiserslautern, Germany
²³Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic
²⁴Department of Haematology and Oncology, University Hospital and Medical Faculty Augsburg, Augsburg, Germany
²⁵Klinikum Augsburg, Augsburg, DEU
²⁶Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany
²⁷Department of Internal Medicine I, University Hospital Dresden, Dresden, Germany
²⁸Universitätsklinikum Dresden, Dresden, Germany
²⁹Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany
³⁰Department of Internal Medicine I, TU Dresden, Dresden, Saxony, Germany
³¹Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany
³²Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany
³³Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden, Germany
³⁴Department of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic
³⁵Universitatsklinikum Cad GustavCarus an der Technischen Universltat Dresden, Dresden, Ferscherstrabo 74, Germany

Nigel H. Russell, MD¹, Charlotte Wilhelm-Benartzi, PhD^2*, Steve Knapper, BMBCh³, Leona M Batten^2*, Joanna Canham^2*, Emily L Hinson, PhD^2*, Ulrik Malthe Overgaard, MD^4*, Amanda Gilkes^5*, Jad Othman, MBBS⁶, Nicola Potter, PhD^6*, Richard Dillon, MA PhD MRCP FRCPath⁶, Priyanka Mehta^7*, Panagiotis Kottaridis, MD, PhD^8*, Jamie Cavenagh, MD, PhD^9*, Claire Hemmaway, MD^10*, Claire Arnold, MD^11*, Sylvie D Freeman, MBChB, MRCP, FRCPath¹² and Mike Dennis, MD, MRCP, FRCPath¹³

¹Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
²Centre for Trials Research, Cardiff University, Cardiff, United Kingdom
³Cardiff University School of Medicine, Cardiff, United Kingdom
⁴Copenhagen University Hospital, Denmark, Denmark
⁵Cardiff University, Cardiff, GBR
⁶Department of Medical and Molecular Genetics, King's College London, London, United Kingdom
⁷The University of Bristol and Weston NHS Trust, Bristol, United Kingdom
⁸University College London Hospital NHS Foundation Trust, London, GBR
⁹Department of Haematology, St Bartholomew's Hospital, London, United Kingdom
¹⁰Auckland City Hospital, Auckland, New Zealand
¹¹Belfast City Hospital, Belfast, United Kingdom
¹²Centre for Clinical Haematology, University Hospitals Birmingham, Birmingham, United Kingdom
¹³Haematology, The Christie NHS Foundation Trust, Manchester, United Kingdom

Keith W. Pratz, MD¹, Brian A. Jonas, MD, PhD², Vinod A. Pullarkat, MD^3*, Michael J. Thirman, MD⁴, Jacqueline S. Garcia, MD⁵, Walter Fiedler, MD⁶, Kazuhito Yamamoto, MD, PhD⁷, Jianxiang Wang, MD⁸, Sung-Soo Yoon, MD, PhD⁹, Ofir Wolach, MD^10*, Jun-Ho Jang, MD^11*, Su-Peng Yeh, MD^12*, Grace Ku, MD¹³, Ying Zhou, PhD^14*, Brenda Chyla, PhD¹⁴, Jalaja Potluri, MD¹⁴ and Courtney D. DiNardo, MD, MSCE¹⁵

¹Division of Hematology and Oncology, Abramson Cancer Center University of Pennsylvania, Philadelphia, PA
²Department of Internal Medicine, Division of Malignant Hematology, Transplantation and Cellular Therapy, University of California Davis School of Medicine, Sacramento, CA
³Department of Hematology and Hematopoietic Cell Transplantation and Gehr Family Center for Leukemia Research, City of Hope Comprehensive Cancer Center, Duarte, CA
⁴Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
⁵Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁶Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Cancer Center Hamburg, University Hospital Eppendorf, Hamburg, Germany
⁷Aichi Cancer Center, Nagoya, Japan
⁸Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁹Division of Hematology/Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
¹⁰Rabin Medical Center, Petah Tikva, Israel
¹¹Division of Hematology-Oncology, Samsung Medical Center, Seoul, Korea, Republic of (South)
¹²China Medical University Hospital, Taichung, Taiwan
¹³Genentech, South San Francisco, CA
¹⁴AbbVie Inc., North Chicago, IL
¹⁵Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Sylvie D Freeman, MBChB, MRCP, FRCPath¹, Abin Thomas^2*, Ian Thomas^2*, Paresh Vyas, DPhil, FRCP, FRCPath, MRCP, MRCPath³, Amanda Gilkes^4*, Marlen Metzner, MSc^3*, Niels Asger Jakobsen, BM BCh MRCP^5*, Alison Kennedy, MSc^6*, Amy Moore^7*, Nuria Marquez Almuina^8*, Sarah Burns^8*, Sophie King^8*, Georgia M. Andrew, BSc^9*, Kathleen M.E. Gallagher, PhD^10*, Rob Sellar, FRCPath, MBBChir^11*, Paul Cahalin, MA MRCP FRCPath^12*, Duruta Weber^13*, Mike Dennis, MD, MRCP, FRCPath¹⁴, Priyanka Mehta^15*, Steve Knapper, BMBCh¹⁶ and Nigel H. Russell, MD¹⁷

¹Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom
²Centre for Trials Research, Cardiff University, Cardiff, United Kingdom
³MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
⁴Cardiff University, Cardiff, GBR
⁵Oxford Centre for Haematology, NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom
⁶Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom
⁷University of Oxford, Oxford, United Kingdom
⁸Cardiff University, Cardiff, United Kingdom
⁹Laboratory of Myeloid Malignancies, National Heart Lung and Blood Institute, Bethesda, MD
¹⁰Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA
¹¹University College London, London, United Kingdom
¹²Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom
¹³Odense Universitetshospital, Odense, DNK
¹⁴Haematology, The Christie NHS Foundation Trust, Manchester, United Kingdom
¹⁵The University of Bristol and Weston NHS Trust, Bristol, United Kingdom
¹⁶Cardiff University School of Medicine, Cardiff, United Kingdom
¹⁷Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom

Sai Prasad Desikan, MD^1*, Marina Konopleva, MD, PhD¹, Koichi Takahashi, MD, PhD², Curtis A Lachowiez, MD^3*, Sanam Loghavi, MD⁴, Lian-Chun Xiao^5*, Tapan M. Kadia, MD¹, Naval Daver, MD¹, Nicholas Short, MD², Koji Sasaki, MD¹, Gautam Borthakur, MD¹, Ghayas C. Issa, MD¹, Abhishek Maiti, MBBS⁶, Kelly S. Chien, MD¹, Yesid Alvarado, MD¹, Guillermo Montalban-Bravo, MD¹, Lucia Masarova, MD¹, Musa Yilmaz, MD⁷, Michael Andreeff, MD, PhD¹, Elias Jabbour, MD¹, Guillermo Garcia-Manero, MD⁸, Steven M. Kornblau, MD¹, Farhad Ravandi, MD¹, Hagop Kantarjian, MD⁹ and Courtney D. DiNardo, MD, MSCE¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
³Department of Medicine, Oregon Health and Science University, Portland, OR
⁴Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston
⁶Department of Leukemia, The University of Texas Health Science Center At Houston, Houston, TX
⁷Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁸Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Christophe Willekens, MD^1*, Samy Chraibi, MD^2*, Justine Decroocq, MD, PhD^3*, Benjamin Carpentier, MD^4*, Delphine Lebon, MD^5*, Sarah Bonnet, MD^6*, Nicolas Gauthier, MD^7*, Arnaud Pagès^8*, Matteo Dragani, MD^1*, Sabine Khalife-Hachem, MD^1*, Jean-Baptiste Micol, MD¹, Florence Pasquier, MD, PhD^1*, Stefan Wickenhauser, MD^2*, Véronique Saada, PharmD^9*, Véronique Vergé, MD^10*, Ahmadreza Arbab^9*, Christophe Marzac, MD^9*, Laurent Pascal, MD, PhD^4*, Damien Roos-Weil, MD, PhD^7*, Eric Jourdan, MD^2*, Didier Bouscary, MD, PhD^3* and Stéphane de Botton, MD, PhD^1*

¹Département d’Hématologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France
²Service d’Hématologie, Centre Hospitalier Universitaire de Nîmes, Nîmes, France
³Service d’Hématologie, Centre Hospitalier Universitaire Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France
⁴Service d’Hématologie, Groupement des Hôpitaux de l'Institut Catholique de Lille, Lille, France
⁵Service d’Hématologie, Centre Hospitalier Universitaire Amiens – Picardie, Amiens, France
⁶Service d’Hématologie, Centre Hospitalier Universitaire de Montpellier, Montpellier, France
⁷Service d’Hématologie, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France
⁸Biostatistique et Epidémiologie, CESP Inserm U1018, Gustave Roussy, Université Paris-Saclay, Villejuif, France
⁹Département de Biologie et Pathologie Médicales, Gustave Roussy, Université Paris-Saclay, Villejuif, France
¹⁰Département de Biologie et Pathologie Médicales, Gustave Roussy/Université Paris-Saclay, Villejuif, France